AZN.L vs. V3AB.L

Last updated Jun 5, 2026

AZN.L (AstraZeneca plc) is a stock, while V3AB.L (Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating) is Global Equities fund tracking the MSCI ACWI NR USD. Over the past 5 years, AZN.L returned 13.33%/yr vs 11.91%/yr for V3AB.L. At a 0.24 correlation, their price movements are largely independent.

Performance

AZN.L vs. V3AB.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in AstraZeneca plc (AZN.L) and Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating (V3AB.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

AZN.L is traded in GBp, while V3AB.L is traded in GBP. To make them comparable, the V3AB.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, AZN.L achieves a -0.69% return, which is significantly lower than V3AB.L's 12.14% return.

AZN.L

• 1D: 2.60%
• 1M: -0.09%
• YTD: -0.69%
• 6M: 0.75%
• 1Y: 28.88%
• 3Y*: 6.86%
• 5Y*: 13.33%
• 10Y*: 16.08%

V3AB.L

• 1D: 0.03%
• 1M: 6.33%
• YTD: 12.14%
• 6M: 12.90%
• 1Y: 30.24%
• 3Y*: 17.81%
• 5Y*: 11.91%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AZN.L vs. V3AB.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
AZN.L AstraZeneca plc	-0.69%	34.59%	0.92%	-3.53%	32.32%	21.32%
V3AB.L Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating	12.14%	12.22%	19.77%	17.95%	-11.67%	17.38%

Correlation

The correlation between AZN.L and V3AB.L is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.24
Correlation (All Time) Calculated using the full available price history since Mar 26, 2021	0.24

Return for Risk

AZN.L vs. V3AB.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AZN.L

AZN.L Risk / Return Rank: 74
AZN.L Sharpe Ratio Rank: 75
AZN.L Sortino Ratio Rank: 75
AZN.L Omega Ratio Rank: 70
AZN.L Calmar Ratio Rank: 73
AZN.L Martin Ratio Rank: 75

V3AB.L

V3AB.L Risk / Return Rank: 80
V3AB.L Sharpe Ratio Rank: 81
V3AB.L Sortino Ratio Rank: 80
V3AB.L Omega Ratio Rank: 83
V3AB.L Calmar Ratio Rank: 76
V3AB.L Martin Ratio Rank: 80

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AZN.L vs. V3AB.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AstraZeneca plc (AZN.L) and Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating (V3AB.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AZN.L	V3AB.L	Difference
Sharpe ratio: Return per unit of total volatility	1.14	2.58	-1.44
Sortino ratio: Return per unit of downside risk	1.98	3.56	-1.58
Omega ratio: Gain probability vs. loss probability	1.22	1.49	-0.27
Calmar ratio: Return relative to maximum drawdown	1.86	3.76	-1.90
Martin ratio: Return relative to average drawdown	4.85	15.42	-10.56
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AZN.L vs. V3AB.L - Sharpe Ratio Comparison

The current AZN.L Sharpe Ratio is 1.14, which is lower than the V3AB.L Sharpe Ratio of 2.58. The chart below compares the historical Sharpe Ratios of AZN.L and V3AB.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	AZN.L	V3AB.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.14	2.58	-1.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.56	0.87	-0.31
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.66	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.91	-0.39

Drawdowns

AZN.L vs. V3AB.L - Drawdown Comparison

The maximum AZN.L drawdown since its inception was -49.99%, which is greater than V3AB.L's maximum drawdown of -19.00%. Use the drawdown chart below to compare losses from any high point for AZN.L and V3AB.L.

Drawdown Indicators

	AZN.L	V3AB.L	Difference
Max Drawdown Largest peak-to-trough decline	-49.99%	-19.00%	-30.99%
Max Drawdown (1Y) Largest decline over 1 year	-15.00%	-8.00%	-7.00%
Max Drawdown (3Y) Largest decline over 3 years	-26.75%	-19.00%	-7.75%
Max Drawdown (5Y) Largest decline over 5 years	-26.75%	-19.00%	-7.75%
Max Drawdown (10Y) Largest decline over 10 years	-26.75%	—	—
Current Drawdown Current decline from peak	-12.79%	-0.55%	-12.24%
Average Drawdown Average peak-to-trough decline	-11.69%	-4.22%	-7.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.77%	1.96%	+3.81%

Volatility

AZN.L vs. V3AB.L - Volatility Comparison

AstraZeneca plc (AZN.L) has a higher volatility of 6.10% compared to Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating (V3AB.L) at 3.38%. This indicates that AZN.L's price experiences larger fluctuations and is considered to be riskier than V3AB.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AZN.L	V3AB.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.10%	3.38%	+2.72%
Volatility (6M) Calculated over the trailing 6-month period	16.92%	8.82%	+8.10%
Volatility (1Y) Calculated over the trailing 1-year period	24.50%	11.66%	+12.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.76%	13.72%	+10.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.32%	13.67%	+10.65%

Dividends

AZN.L vs. V3AB.L - Dividend Comparison

AZN.L's dividend yield for the trailing twelve months is around 1.74%, while V3AB.L has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AZN.L AstraZeneca plc	1.74%	1.77%	2.23%	2.21%	1.98%	2.33%	2.95%	2.87%	3.44%	4.28%	4.50%	3.95%
V3AB.L Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating	0.00%	0.00%	0.00%	0.00%	1.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both AZN.L and V3AB.L in my portfolio?

AZN.L and V3AB.L have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.